Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Kristin Pothier
The rapidly accelerating complexity of oncology drug development demands a new way of doing business. To succeed in this new landscape, biopharma companies must transform their portfolios and partnerships, and shift toward more dynamic business and operating models and decision-making processes.
Pharma is seeking Big Data's assistance in many stages of the cancer drug discovery and development process. A look at some recent collaborations.